These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8907798)

  • 1. Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias.
    Nakamura M; Xue Y; Eto K; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Mar; 27(3):368-75. PubMed ID: 8907798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic plasma concentrations of NIK-244 on canine ventricular arrhythmias.
    Hashimoto K; Matsuzaki T; Haruno A
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):892-8. PubMed ID: 2481779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K; Ishii M; Komori S; Mitsuhashi H
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effects of optical isomers of cibenzoline on canine ventricular arrhythmias.
    Haruno A; Matsuzaki T; Hashimoto K
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):376-82. PubMed ID: 1700207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiarrhythmic effects of pilsicainide hydrochloride and effects on cardiac function and ECG in dogs: comparison with disopyramide].
    Hidaka T; Inoue T; Komoriya K; Hayashi Y; Inomata N
    Nihon Yakurigaku Zasshi; 2000 May; 115(5):295-308. PubMed ID: 10872181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, AN-132, on ventricular arrhythmias in beagles.
    Hashimoto K; Watanabe K; Mitsuhashi H
    Cardiovasc Drugs Ther; 1989 Oct; 3(5):683-9. PubMed ID: 2488108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of a new antiarrhythmic drug, KW-3407, on canine ventricular arrhythmia models].
    Wu Z; Awaji T; Motomura S; Hashimoto K
    Nihon Yakurigaku Zasshi; 1992 Aug; 100(2):117-26. PubMed ID: 1427497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
    Haruno A; Hashimoto K
    Jpn J Pharmacol; 1995 May; 68(1):95-102. PubMed ID: 7494388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of NS-2, a new class 1 antiarrhythmic agent, and AFD-19, its active metabolite, on ventricular arrhythmias induced by coronary artery occlusion and reperfusion in anesthetized rats: comparison with disopyramide and mexiletine.
    Komori S; Sawanobori T; Tamura K; Kane KA; Parratt JR
    Jpn J Pharmacol; 1994 Jul; 65(3):193-200. PubMed ID: 7799519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic plasma concentrations of pirmenol on canine ventricular arrhythmias.
    Hashimoto K; Watanabe K; Sugiyama A
    Jpn J Pharmacol; 1988 Oct; 48(2):273-82. PubMed ID: 3210450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs.
    Chen J; Xue Y; Eto K; Ni C; Hashimoto K
    J Cardiovasc Pharmacol; 1996 Oct; 28(4):576-84. PubMed ID: 8891885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia.
    Awaji T; Wu ZJ; Hashimoto K
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):869-78. PubMed ID: 8606522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations.
    Hashimoto K; Shibuya T; Satoh H; Imai S
    Jpn Circ J; 1983 Jan; 47(1):92-7. PubMed ID: 6827775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lidocaine, disopyramide and verapamil on the in vivo triggered ventricular arrhythmia in digitalized canine heart.
    Akiyama K; Hashimoto K
    Jpn J Pharmacol; 1990 Aug; 53(4):419-26. PubMed ID: 2214367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias.
    Hashimoto K; Ishii M; Komori S
    J Cardiovasc Pharmacol; 1984; 6(2):213-9. PubMed ID: 6200706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic profile of a new class 1 drug, AHR 10718, on canine atrial and ventricular arrhythmia models.
    Mitsuhashi H; Hashimoto K
    Jpn J Pharmacol; 1988 Apr; 46(4):349-58. PubMed ID: 3404765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models.
    Xue Y; Tanabe S; Nabuchi Y; Hashimoto K
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):239-47. PubMed ID: 9700986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.